Adam E. Mullick
About
Adam E. Mullick is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery.
According to data from OpenAlex, Adam E. Mullick has authored 79 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cardiology and Cardiovascular Medicine, 21 papers in Molecular Biology and 18 papers in Surgery. Recurrent topics in Adam E. Mullick's work include Atherosclerosis and Cardiovascular Diseases (12 papers), Lipid metabolism and disorders (11 papers) and Renin-Angiotensin System Studies (10 papers). Adam E. Mullick is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (12 papers), Lipid metabolism and disorders (11 papers) and Renin-Angiotensin System Studies (10 papers). Adam E. Mullick collaborates with scholars based in United States, Netherlands and China. Adam E. Mullick's co-authors include Mark J. Graham, Rosanne M. Crooke, Richard Lee, Ira J. Goldberg, Thomas A. Bell, John C. Rutledge, Parisa Kalantari, Eicke Latz, Lynda M. Stuart and Susan Carpenter and has published in prestigious journals such as Nucleic Acids Research, Circulation and Journal of Clinical Investigation.
In The Last Decade
Adam E. Mullick
74 papers receiving 3.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Adam E. Mullick United States | 32 | 1.5k | 1.1k | 1.0k | 966 | 885 | 79 | 4.0k | ||
| Marit Westerterp Netherlands | 40 | 1.9k 1.3× | 1.7k 1.6× | 1.8k 1.8× | 641 0.7× | 774 0.9× | 77 | 5.1k | ||
| Ewa Ninio France | 37 | 1.4k 0.9× | 1.0k 0.9× | 1.2k 1.1× | 576 0.6× | 570 0.6× | 103 | 4.1k | ||
| Nicolas Venteclef France | 33 | 1.5k 1.0× | 925 0.8× | 807 0.8× | 830 0.9× | 361 0.4× | 75 | 3.8k | ||
| Lisa R. Tannock United States | 32 | 1.3k 0.8× | 460 0.4× | 1.1k 1.1× | 456 0.5× | 841 1.0× | 81 | 3.4k | ||
| Francesco Paolo Mancini Italy | 32 | 1.5k 1.0× | 618 0.6× | 803 0.8× | 554 0.6× | 404 0.5× | 86 | 3.9k | ||
| Carmen Gómez‐Guerrero Spain | 40 | 1.5k 1.0× | 1.3k 1.2× | 481 0.5× | 466 0.5× | 461 0.5× | 92 | 4.5k | ||
| Lillemor Mattsson Hultén Sweden | 28 | 1.1k 0.8× | 942 0.9× | 920 0.9× | 504 0.5× | 374 0.4× | 74 | 3.2k | ||
| Friedrich Thaiss Germany | 35 | 1.2k 0.8× | 1.2k 1.1× | 577 0.6× | 813 0.8× | 554 0.6× | 116 | 4.9k | ||
| Weibin Shi United States | 26 | 1.1k 0.7× | 1.0k 1.0× | 561 0.5× | 388 0.4× | 445 0.5× | 110 | 3.1k | ||
| Prabhakara R. Nagareddy United States | 31 | 1.2k 0.8× | 1.1k 1.0× | 428 0.4× | 563 0.6× | 430 0.5× | 68 | 3.1k |
Countries citing papers authored by Adam E. Mullick
Since
Specialization
Citations
This map shows the geographic impact of Adam E. Mullick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam E. Mullick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam E. Mullick more than expected).
Fields of papers citing papers by Adam E. Mullick
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Adam E. Mullick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam E. Mullick. The network helps show where Adam E. Mullick may publish in the future.
Co-authorship network of co-authors of Adam E. Mullick
This figure shows the co-authorship network connecting the top 25 collaborators of Adam E. Mullick. A scholar is included among the top collaborators of Adam E. Mullick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam E. Mullick. Adam E. Mullick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Peng, Xueying, Zeqin Lian, Xiaoyuan Dai Perrard, et al.. (2025). Foamy monocytes and atherogenesis in mice with combined hyperlipidemia and effects of antisense knockdown of apoCIII. Journal of Lipid Research. 66(4). 100763–100763.
2.
DeBerge, Matthew, Connor Lantz, Zhi‐Dong Ge, et al.. (2025). Mechanical regulation of macrophage metabolism by allograft inflammatory factor 1 leads to adverse remodeling after cardiac injury. Nature Cardiovascular Research. 4(1). 83–101.
3.
Franklin, Michael, Masayoshi Kukida, Jessica J. Moorleghen, et al.. (2024). Renal Proximal Tubule Cell-Specific Megalin Deletion Does Not Affect Atherosclerosis But Induces Tubulointerstitial Nephritis in Mice Fed a Western Diet. Arteriosclerosis Thrombosis and Vascular Biology. 45(1). 74–89.
4.
Kramer, Farah, Shreeram Akilesh, Charles E. Alpers, et al.. (2024). Elevated apolipoprotein C3 augments diabetic kidney disease and associated atherosclerosis in type 2 diabetes. JCI Insight. 9(12).
5.
Shridas, Preetha, Ailing Ji, Victoria P. Noffsinger, et al.. (2024). Antisense oligonucleotide targeting hepatic Serum Amyloid A limits the progression of angiotensin II-induced abdominal aortic aneurysm formation. Atherosclerosis. 391. 117492–117492.
6.
Thompson, Janice, Huirong Xie, Elena Y. Demireva, et al.. (2023). Chemerin is resident to vascular tunicas and contributes to vascular tone. American Journal of Physiology-Heart and Circulatory Physiology. 325(1). H172–H186.
7.
Trainor, Patrick J., Michela Brambatti, Samantha M. Carlisle, et al.. (2023). Blood Levels of Angiotensinogen and Hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA). Journal of the American College of Cardiology. 81(13). 1248–1259.
8.
Ramms, Bastian, Xiaoli Sun, Ariane Pessentheiner, et al.. (2022). Interventional hepatic apoC-III knockdown improves atherosclerotic plaque stability and remodeling by triglyceride lowering. JCI Insight. 7(13).
9.
Cabodevilla, Ainara G., Ni-Huiping Son, Yunying Hu, et al.. (2022). Blocking Lipid Uptake Pathways Does not Prevent Toxicity in Adipose Triglyceride Lipase (ATGL) Deficiency. Journal of Lipid Research. 63(11). 100274–100274.
10.
Sawada, Hisashi, Michael Franklin, Jessica J. Moorleghen, et al.. (2022). LRP1 protects against excessive superior mesenteric artery remodeling by modulating angiotensin II–mediated signaling. JCI Insight. 8(2).
11.
Sawada, Hisashi, Dien Ye, Michael Franklin, et al.. (2022). Inhibition of the Renin-Angiotensin System Fails to Suppress β-Aminopropionitrile–Induced Thoracic Aortopathy in Mice—Brief Report. Arteriosclerosis Thrombosis and Vascular Biology. 42(10). 1254–1261.
12.
Eijgenraam, Tim R., Remco de Brouwer, Elisabeth M. Schouten, et al.. (2022). Antisense Therapy Attenuates Phospholamban p.(Arg14del) Cardiomyopathy in Mice and Reverses Protein Aggregation. International Journal of Molecular Sciences. 23(5). 2427–2427.
13.
Nikan, Mehran, Steve T. Yeh, Alfred E. Chappell, et al.. (2022). Targeted Delivery of Antisense Oligonucleotides Through Angiotensin Type 1 Receptor. Nucleic Acid Therapeutics. 32(4). 300–311.
14.
Chen, Jeff Z., Hisashi Sawada, Dien Ye, et al.. (2021). Deletion of AT1a (Angiotensin II Type 1a) Receptor or Inhibition of Angiotensinogen Synthesis Attenuates Thoracic Aortopathies in Fibrillin1 C1041G/+ Mice. Arteriosclerosis Thrombosis and Vascular Biology. 41(10). 2538–2550.
15.
Rong, Jiabing, Yao Lin, Hong Lü, et al.. (2021). Loss of Hepatic Angiotensinogen Attenuates Sepsis-Induced Myocardial Dysfunction. Circulation Research. 129(5). 547–564.
16.
Radkë, Michaël, Thiago Britto‐Borges, Dieter A. Kubli, et al.. (2021). Therapeutic inhibition of RBM20 improves diastolic function in a murine heart failure model and human engineered heart tissue. Science Translational Medicine. 13(622). eabe8952–eabe8952.
17.
Cabodevilla, Ainara G., Songtao Tang, Sungwoon Lee, et al.. (2021). Eruptive xanthoma model reveals endothelial cells internalize and metabolize chylomicrons, leading to extravascular triglyceride accumulation. Journal of Clinical Investigation. 131(12).
18.
Morgan, Erin, Kevin Hu, Adam E. Mullick, et al.. (2021). EFFECT OF IONIS-AGT-LRX IN SUBJECTS WITH UNCONTROLLED HYPERTENSION ON 2-3 MEDICATIONS: RESULTS OF A PHASE 2 STUDY. Journal of the American College of Cardiology. 77(18). 1547–1547.
19.
Souza, Ana C. P., Alexander V. Bocharov, Irina N. Baranova, et al.. (2016). Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation. Kidney International. 89(4). 809–822.
20.
Mullick, Adam E., Katrin Soldau, William B. Kiosses, et al.. (2008). Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events. The Journal of Experimental Medicine. 205(2). 373–383.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Marit Westerterp Breakdown of academic impact, for papers by Ewa Ninio Breakdown of academic impact, for papers by Nicolas Venteclef Breakdown of academic impact, for papers by Lisa R. Tannock Breakdown of academic impact, for papers by Francesco Paolo Mancini Breakdown of academic impact, for papers by Carmen Gómez‐Guerrero Breakdown of academic impact, for papers by Lillemor Mattsson Hultén Breakdown of academic impact, for papers by Friedrich Thaiss Breakdown of academic impact, for papers by Weibin Shi Breakdown of academic impact, for papers by Prabhakara R. Nagareddy